Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for atopic dermatitis.

Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for atopic dermatitis. - Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for atopic dermatitis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036155

Enrollment

Registered

2019-03-15

Start date

2019-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

attached the short wavelength cut filter not attached the short wavelength cut filter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Atopic dermatitis patients who are poor controlled with topical anti-inflammatory agent, oral antihistamine agent and moisturizing agent. -Patient who is candidates for phototherapy.

Exclusion criteria

Exclusion criteria: -Patient who is not candidates for phototherapy -Pregnant or possibly pregnant women, or breastfeeding women. Women who wish to become pregnant during study participation -Patients who are judged inappropriate to participate in the study by the investigator

Design outcomes

Primary

Measure	Time frame
skin pigmentation of irradiation area	—

Countries

Japan

Contacts

Public ContactMorita Akimichi

Nagoya City University Graduate School of Medical Sciences Department of Geriatric and Environmental Dermatology

amorita@med.nagoya-cu.ac.jp052-853-8261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026